Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review Article · Übersichtsarbeit

Recent Advances in Platelet Transcriptomics

Gnatenko D.V.a · Bahou W.F.a,b

Author affiliations

aDepartment of Medicine, bProgram in Genetics, State University of New York, Stony Brook, NY, USA

Related Articles for ""

Transfus Med Hemother 2006;33:217-226

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Platelets are anucleated cells that contain small amounts of mRNA of megakaryocyte origin and possess the capacity for signal-dependent pre-mRNA splicing. They have an important role in diverse hemostatic and pathological disorders, including vascular remodeling, inflammation and wound repair. Recent progress in highthroughput mRNA profiling techniques permitted first insights into the platelet transcriptome - a catalogue of all mRNA transcripts expressed in platelets. It is evident that platelets have a unique and reproducible molecular signature. Detailed analysis of the platelet transcriptome has resulted in the identification of many genes and proteins, previously unknown to be expressed in platelets. Furthermore, microarray analysis was applied to platelet disorders: i) as potentially a powerful tool for differential diagnosis, ii) to study the molecular basis of the disease and iii) to identify potential targets for therapy. In this review, we focus on recent applications of transcript profiling to platelet studies. We briefly review current approaches to transcriptome analysis and describe practical application of these approaches to investigate molecular mechanisms of essential thrombocythemia, gray platelet syndrome and polycythemia vera.

Article / Publication Details

First-Page Preview
Abstract of Review Article · Übersichtsarbeit

Published online: May 23, 2006
Issue release date: June 2006

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0

ISSN: 1660-3796 (Print)
eISSN: 1660-3818 (Online)

For additional information: http://www.karger.com/TMH

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.